ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 120 filers reported holding ARCELLX INC in Q1 2023. The put-call ratio across all filers is 1.54 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $346,980 | -51.0% | 6,287 | -38.2% | 0.05% | -45.6% |
| Q1 2024 | $707,810 | +126.4% | 10,177 | +80.7% | 0.09% | +47.5% |
| Q4 2023 | $312,576 | +598.1% | 5,632 | +351.3% | 0.06% | +369.2% |
| Q3 2023 | $44,778 | +125.1% | 1,248 | +98.4% | 0.01% | +116.7% |
| Q2 2023 | $19,889 | +8.7% | 629 | +5.9% | 0.01% | 0.0% |
| Q1 2023 | $18,301 | +32.8% | 594 | +33.5% | 0.01% | 0.0% |
| Q4 2022 | $13,786 | – | 445 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 5,500,007 | $170,390,217 | 62.20% |
| PATHWAY CAPITAL MANAGEMENT, LP | 189,120 | $5,858,938 | 10.46% |
| NEA Management Company, LLC | 4,745,262 | $147,008,217 | 8.26% |
| Samsara BioCapital, LLC | 957,451 | $29,661,832 | 6.38% |
| Soleus Capital Management, L.P. | 1,102,447 | $34,153,808 | 4.90% |
| Cormorant Asset Management, LP | 2,075,000 | $64,284 | 4.30% |
| Paradigm Biocapital Advisors LP | 882,101 | $27,327,489 | 3.21% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,350,333 | $72,813,316 | 3.06% |
| Affinity Asset Advisors, LLC | 240,143 | $7,439,630 | 2.92% |
| CAXTON CORP | 36,302 | $1,124,640 | 2.87% |